Model of STreptococcus pneumoniae meningitis in adult rats

Laboratory Animal Science

Volumn 46, Issue 5, 1996, Pages 524-529

  Strake, James G ^a   Mitten, Michael J ^a   Ewing, Patty J ^a   Alder, Jeffrey D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; GENTAMICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL INFECTION; NONHUMAN; RAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN; CEFOTAXIME; CEREBROSPINAL FLUID; DISEASE MODELS, ANIMAL; GENTAMICINS; MALE; MENINGES; MENINGITIS; RATS; RATS, SPRAGUE-DAWLEY; RODENT DISEASES; RODENTIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0029804754     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Berkow, R., and J. J. Fletcher. 1987. The Merck manual of diagnosis and therapy, 5th ed., p. 1395-1401. Merck Sharp & Dohme Research Laboratories, Rahway, N.J.
2. Schlech, E. F., III., J. I. Ward, J. D. Band, et al. 1985. Bacterial meningitis in the United States, 1978 through 1981: the national bacterial meningitis surveillance study. JAMA 253:1749-1754.
3. Wenger, J. D., A, W. Hightower, R. R. Facklam, et al. 1990. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. 162:1316-1323.
4. Tunkel, A. R., and W. M. Scheld. 1993. Pathogenesis and pathophysiology of bacterial meningitis. Ann. Rev. Med. 44:103-120.
5. Saez-Llorens, X., O. Ramilo, M. M. Mustafa, et al. 1990. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J. Pediatr. 116:671-684.
6. Dodge, P. R., H. Davis, R. D. Feigin, et al. 1984. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N. Engl. J. Med. 311:869-874.
7. Jawetz, E., J. L. Melnick, and E. A. Adelberg. 1987. Review of medical microbiology, 17th ed., p. 229-231. Appleton and Lange, Los Altos, Calif.
8. Saukkonen, K. 1988. Experimental meningococcal meningitis in the infant rat. Microb. Pathol. 4:203-211.
9. Sulc, P., B. Hengstler, G. Krinke, et al. 1992. Experimental rabbit model of meningitis produced by Haemophilus influenzas serotype C. J. Med. Microbiol. 36:312-317.
10. Bhatt, S., C. Halpin, W. Hsu, et al. 1991. Hearing loss and pneumococcal meningitis: an animal model. Laryngoscope 101:1285-1292.
11. Rodriguez, A. F., S. L. Kaplan, E. P. Hawking, et al. 1991. Hematogenous pneumococcal meningitis in the infant rat: description of a model. J. Infect. Dis. 164:1207-1209.
12. Salit, I. E., and L. Tomalty. 1986. A neonatal mouse model of meningococcal disease. Clin. Invest. Med. 9:119-123.
13. Salit, I. E., and L. Tomalty. 1986. Experimental meningococcal infection in mice: a model for mucosal invasion. Infect. Immun. 51:648-652.
14. Geibink, G. S., G. Schiffman, K. Petty, et al. 1978. Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J. Infect. Dis. 138:480-487.
15. Giebink, G. S., I. K. Berzins, G. Schiffman, et al. 1979. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide. J. Infect. Dis. 140:716-723.
16. Petersdorf, R. G., D. R. Swarner, and M. Garcia. 1962. Studies on the pathogenesis of meningitis during pneumococcal bacteremia. J. Clin. Invest. 41:320-327.
17. Institute of Laboratory Animal Resources. 1978. Guide for the care and use of laboratory animals, p. 13-14. U.S. Department of Health and Human Services, Institute of Laboratory Animal Resources, Bethesda, Md.
18. Nairn, K., G. L. Shepherd, and J. R. Edwards. 1995 Efficacy of meropenem in experimental meningitis. J. Antimicrob. Chemother. 36(Suppl. A):73-83.
19. Norrby, S. R. 1985. Role of cephalosporins in the treatment of bacterial meningitis in adults: overview with special emphasis on ceftazidime. Am. J. Med. 79:56-61.
20. Tunkel, A. R., and W. M. Scheld. 1991. Acute therapy of bacterial meningitis. J. Intensive Care Med. 6:229-237.
21. Krogstad, D. J., and R. C. Moellering. 1986. Antimicrobial combinations, p. 537-595. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore.
22. Smith, A. L., R. S. Daum, G. Siber, et al. 1988. Gentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitis. Antimicrob. Agents Chemother. 32:1034-1037.
23. Baggot, J. D. 1982. Disposition and fate of drugs in the body, p. 36-69. In N. H. Booth and L. E. McDonald (ed.), Veterinary pharmacology and therapeutics. Iowa State University Press, Ames, Iowa.
24. Flecknell, P. A. 1989. Laboratory animal anesthesia, p. 131. Academic Press, Inc., San Diego, Calif.
25. Harkness, J. E., and J. E. Wagner. 1995. The biology and medicine of rabbits and rodents, 4th ed., p. 76. The Williams & Wilkins Co., Media, Pa.
26. Neu, H. C. 1987. Cephalosporins in the treatment of meningitis. Drugs 34:135-153.
27. Paris, M. M., S. M. Hickey, M. Trujillo, et al. 1995. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 39:1243-1246.
28. Calandra, G. B., C. Wang, M. Aziz, et al. 1986. The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients. J. Antimicrob. Chemother. 18 (Suppl. E):193-202.
29. Friedland, I. R., M. Paris, S. Ehrett, et al. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1630-1636.
30. Lebel, M. H., B. J. Freij, G. A. Syrogiannopoulos, et al. 1988. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N. Engl. J. Med. 319:964-971.
31. Odio, C. M., I. Faingezicht, M. Nassar, et al. 1991. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 324:1525-1531.
32. Girgis, N. I., Z. Farid, I. A. Mikhail, et al. 1989. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr. Infect. Dis. J. 8:848-851.
33. Sable, C., A. R. Tunkel, and W. M. Scheld. 1993. Adjunctive dexamethasone in the therapy of bacterial meningitis. Infect. Med. 10:49-55.
34. Rooney, P., G. Bilbe, O. Zak, et al. 1995. Dexamethasone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy. J. Med. Microbiol. 43:37-44.
35. Bhatt, S. M., C. Cabellos, J. B. Nadol, et al. 1995. The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis. Pediatr. Infect. Dis. J. 14:93-96.